Join
Live feed
·
INSIDERFilingvia Quantisnow
Vera Therapeutics Inc. logo

PRESIDENT AND CEO Fordyce Marshall sold $701,769 worth of shares (18,500 units at $37.93) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 198,244 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VERA· Vera Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VERA (Vera Therapeutics Inc.) and more on Quantisnow.